A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine

Ingrida Platais, Tamar Tsereteli, Galyna Maystruk, Dilfuza Kurbanbekova, Beverly Winikoff

Open source

DOI
10.1136/bmjsrh-2018-200167
Published
2019-06-04
Container
BMJ Sexual & Reproductive Health
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjsrh-2018-200167,
  title = {A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine},
  author = {Ingrida Platais and Tamar Tsereteli and Galyna Maystruk and Dilfuza Kurbanbekova and Beverly Winikoff},
  year = {2019},
  journal = {BMJ Sexual \& Reproductive Health},
  doi = {10.1136/bmjsrh-2018-200167},
  url = {https://doi.org/10.1136/bmjsrh-2018-200167}
}

RIS

TY  - JOUR
TI  - A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine
AU  - Ingrida Platais
AU  - Tamar Tsereteli
AU  - Galyna Maystruk
AU  - Dilfuza Kurbanbekova
AU  - Beverly Winikoff
PY  - 2019
JO  - BMJ Sexual & Reproductive Health
DO  - 10.1136/bmjsrh-2018-200167
UR  - https://doi.org/10.1136/bmjsrh-2018-200167
ER  - 

APA

Platais, I., Tsereteli, T., Maystruk, G., Kurbanbekova, D., & Winikoff, B. (2019). A prospective study of mifepristone and unlimited dosing of sublingual misoprostol for termination of second-trimester pregnancy in Uzbekistan and Ukraine. BMJ Sexual & Reproductive Health. https://doi.org/10.1136/bmjsrh-2018-200167

Source records